OOIR: Observatory of International Research

Papers

(The H4-Index of BMJ Open Diabetes Research & Care is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Role of 2-hour plasma glucose in assessing pre-diabetes risk: insights from the vitamin D and type 2 diabetes (D2d) study cohort	121
Effects of insonification on repairing the renal injury of diabetic nephropathy rats	63
Offloading devices for neuropathic foot ulcers in adult persons with type 1 or type 2 diabetes: a rapid review with meta-analysis and trial sequential analysis of randomized controlled trials	59
Characterization of the zebrafish as a model of ATP-sensitive potassium channel hyperinsulinism	46
Cardiovascular disease risk factors and their associations with inflammation among US adolescents: NHANES, 2015 to March 2020	44
Diagnostic accuracy of the 5.07 monofilament test for diabetes polyneuropathy: influence of age, sex, neuropathic pain and neuropathy severity	43
Association of body indices and risk of mortality in patients with type 2 diabetes	42
Elevated FIB-4 index as a risk marker within the KDIGO framework in patients with type 2 diabetes and hypertension	41
Co-segregation analysis and functional trial in vivo of candidate genes for monogenic diabetes	40
Association between RDW-SD and prognosis across glycemic status in patients with dilated cardiomyopathy	39
Inflammatory profile of diabetic ketoacidosis in children with type 1 diabetes	38
Biobanking in Latinos: current status, principles for conduct, and contribution of a new biobank, El Banco por Salud, designed to improve the health of Latino patients of Mexican ancestry with type 2	38
Effects of concurrent aerobic and strength training in patients with type 2 diabetes: Bayesian pairwise and dose-response meta-analysis	35
Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial	35
Comparative risk of type 2 diabetes development between women with gestational diabetes and women with impaired glucose tolerance over two decades: a multiethnic prospective cohort in New Zealand	34
Zero Dollar Drug Copay program improves antidiabetic medication adherence and medication use patterns among Blue Cross and Blue Shield of Louisiana members with diabetes in Louisiana	34
Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus	33
Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study	31
Clustering patterns in Finnish type 1 diabetes patients: a nationwide register-based study	31
Association of hemoglobin A1c time in range with risk for diabetes complications	28
Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments	28
Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study	26
Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study	25
Unfavorable social determinants of health and risk of mortality in adults with diabetes: findings from the National Health Interview Survey	25
Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study	24

Retrospective cohort study to examine the association between serum amylase and the incidence of type 2 diabetes mellitus, Toranomon Hospital Health Management Center Study 23 (TOPICS 23)